ESPINOZA OCTAVIO (Chief Financial Officer) reported 1 transaction at LIGAND PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 7/6/2026ACC: 0002001011-26-000107
Officer· Chief Financial Officer
Since Mar 2026
+17.00
Net shares
Net buyer
$2.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
17.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+17.00
Price / share
$160.71
Trade value
$2.73K
% of position
0.1%
6/30/2026
27.68K→27.70K
Total
Net shares
+17.00
Net value
$2.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | J · J | +17.00 | $160.71 | $2.73K | 0.1% | 27.68K | 27.70K |
| Total | +17.00 | $2.73K | ||||||
Derivative Transactions0
No derivative transactions reported